Clinical Trial Update: Randomized, Split-body, Single-blinded Clinical Trial of NB-UVB Treatment for Vitiligo [NA]

View source ↗

Summary

A randomized, split-body, single-blind trial evaluating NB-UVB phototherapy for vitiligo was terminated. Trial results were posted on 2017-12-11.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• NB-UVB Therapy (narrow-band ultraviolet B phototherapy)

Snippet

Sponsor: Johns Hopkins University | Conditions: Vitiligo, Pigmentation | NA | Status: TERMINATED | Results posted: 2017-12-11